Macrolide-lincosamide-streptogramin resistance patterns in Clostridium perfringens from animals.
Different patterns of resistance against commonly used macrolide, lincosamide, and streptogramin antibiotics were found in Clostridium perfringens of animal origin. The patterns were designated as (i) macrolide-lincosamide-streptogramin group B generalized resistance, (ii) macrolide-lincosamide generalized resistance, (iii) macrolide-lincosamide inducible resistance, and (iv) macrolide-lincosamide-streptogramin low-level generalized resistance. The strains of the fourth pattern were able to inactivate pristinamycin and virginiamycin. The macrolide-susceptible strains showed a bimodal distribution of lincomycin and clindamycin susceptibility levels. The susceptible strains were inhibited by 0.25 micrograms of lincomycin per ml and 0.03 micrograms of clindamycin per ml. The low-level resistant strains were inhibited at concentrations of 2 to 4 micrograms of lincomycin per ml and 0.5 to 2 micrograms of clindamycin per ml.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002417:Cattle; D002981:Clindamycin / Q000494:pharmacology; D003016:Clostridium perfringens / Q000187:drug effects*; D003470:Culture Media; D004352:Drug Resistance, Microbial; D008034:Lincomycin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D013552:Swine; D014769:Virginiamycin / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D003470:Culture Media; D014769:Virginiamycin; D002981:Clindamycin; D008034:Lincomycin